between 1974 and 1977 , 652 patients with non-hodgkin 's lymphoma without prior chemotherapy were randomized to 1 of 3 combination chemotherapy programs designed to induce complete remission ( cr ) : cop-bleomycin ( 180 patients ) , chop-bleomycin ( 232 patients ) or chop plus immunotherapy with bacillus calmette guerin ( bcg ) ( 240 patients ) .
C0024305
non-hodgkin 's lymphoma
C0005740
bleomycin